Prothracarcin is an antibiotic with antitumor properties, exerting its cytotoxic effects on tumor cells by covalently bonding to the C-2 amino group of guanine residues in the DNA minor groove. Prothracarcin also exhibits antibacterial activity against certain Gram-positive bacteria and some Gram-negative bacteria, such as Escherichia coli (E. coli).